Filing Flows › Ironwood Pharmaceuticals (IRWD) › Net income
Ironwood Pharmaceuticals (IRWD) net income by quarter
Ironwood Pharmaceuticals' net income was $59.8M in Q3 2026 (third quarter 2026), +17% from Q2 2026. Over the last 5 quarters it ranged from $23.6M (Q2 2025) to $59.8M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $59.8M | +17% | +49% |
| Q2 2026 | $51.3M | +26% | +117% |
| Q1 2026 | $40.8M | +2% | — |
| Q3 2025 | $40.1M | +70% | — |
| Q2 2025 | $23.6M | — | — |
Q3 2026 at a glance
Ironwood Pharmaceuticals, Q3 2026: revenue $133M (+9% year over year), operating margin 70.0%, net earnings $59.8M, operating cash flow $67.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ironwood Pharmaceuticals' net income?
Ironwood Pharmaceuticals' net income was $59.8M in Q3 2026 (third quarter 2026), +17% from Q2 2026.
How has Ironwood Pharmaceuticals' net income changed?
Over the last 5 quarters it ranged from $23.6M (Q2 2025) to $59.8M (Q3 2026).
Q3 2026 results → · How Ironwood Pharmaceuticals makes money →